LLY

1,149.97

-0.44%↓

JNJ

241.07

+0.11%↑

ABBV

224.33

-1.15%↓

UNH

408.18

-0.31%↓

MRK

120.92

+1.34%↑

LLY

1,149.97

-0.44%↓

JNJ

241.07

+0.11%↑

ABBV

224.33

-1.15%↓

UNH

408.18

-0.31%↓

MRK

120.92

+1.34%↑

LLY

1,149.97

-0.44%↓

JNJ

241.07

+0.11%↑

ABBV

224.33

-1.15%↓

UNH

408.18

-0.31%↓

MRK

120.92

+1.34%↑

LLY

1,149.97

-0.44%↓

JNJ

241.07

+0.11%↑

ABBV

224.33

-1.15%↓

UNH

408.18

-0.31%↓

MRK

120.92

+1.34%↑

LLY

1,149.97

-0.44%↓

JNJ

241.07

+0.11%↑

ABBV

224.33

-1.15%↓

UNH

408.18

-0.31%↓

MRK

120.92

+1.34%↑

Accueil・Liste d'Actions・Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

Ouvert

11.11 -1.33

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.96

Max

11.58

Chiffres clés
By Trading Economics
Revenu	-1.4M -14M
BPA	-0.15
Employés	37
EBITDA	-2.7M -15M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+183.15% upside

Dividendes
By Acuity
Prochains Résultats	6 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-410M 938M
Ouverture précédente	12.44
Clôture précédente	11.11

Corvus Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 juin 2026, 23:56 UTC

Macro News

ETF Constituents

Correlated Moves

The iShares Global Infrastructure ETF is lower in after-market hours, influenced by declines in the Canadian market and rising geopolitical tensions.

10 juin 2026, 23:56 UTC

JD.Com Inc. is trading roughly flat in after-market hours, with performance reflecting a position about 6.33% below its 20-day moving average.

10 juin 2026, 23:56 UTC

Cisco Systems shares are lower in after-market trading, continuing a trend of three consecutive sessions finishing down. No specific news was identified for the decline.

10 juin 2026, 23:53 UTC

News

Correlated Moves

Silver/GBP declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also trades lower.

10 juin 2026, 23:52 UTC

News

Correlated Moves

SPDR Gold Shares are trading lower after reports of explosions in Tehran raise regional stability concerns, prompting investors to seek safe-haven assets.

10 juin 2026, 23:52 UTC

News

Correlated Moves

Silver/JPY is trading lower as geopolitical tensions in Iran affect investor sentiment and contribute to fluctuations in precious metals. Gold's decline also impacts silver prices.

10 juin 2026, 23:52 UTC

News

Correlated Moves

Silver prices are lower amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes.

10 juin 2026, 23:52 UTC

News

Correlated Moves

Silver/CAD declines amid geopolitical tensions in Iran and rising U.S. inflation, reversing a trend of higher daily closes. Gold also trades lower in correlation.

10 juin 2026, 23:52 UTC

News

Correlated Moves

Silver declines amid geopolitical tensions in Iran and rising U.S. inflation, breaking a recent trend of higher daily closes. Gold also shows a downward movement.

10 juin 2026, 23:51 UTC

Amgen Inc. shares declined in after-market trading, continuing a trend of lower daily closes amid rising Treasury yields and weakness in technology stocks.

10 juin 2026, 23:51 UTC

Social Media

CSX shares advance in after-market trading, driven by recognition of the Howard Street Tunnel Project by RTS Magazine as a top 2026 project.

10 juin 2026, 23:51 UTC

Fastenal shares are higher in after-market trading, supported by a rise in the Trading Companies & Distributors sub-sector. The stock remains above its 20-day moving average.

10 juin 2026, 23:51 UTC

Global equity markets decline amid U.S.-Iran tensions and mixed economic data, as inflation concerns rise ahead of key Federal Reserve decisions.

10 juin 2026, 23:51 UTC

Asia equity markets decline amid U.S.-Iran tensions and mixed economic signals from China, while investors brace for U.S. inflation data impacting Federal Reserve policy.

10 juin 2026, 23:51 UTC

European equity markets decline amid U.S.-Iran tensions and weak UK housing data, while investors await ECB rate hike and U.S. inflation figures.

10 juin 2026, 23:51 UTC

US equity markets decline amid rising geopolitical tensions with Iran and persistent inflation concerns ahead of key economic data.

10 juin 2026, 23:51 UTC

UK House Price Balance Data Shows Deeper Decline at -0.35%, Heightening Economic Concerns Amid Global Uncertainties

10 juin 2026, 23:51 UTC

South Korea's unemployment rate holds steady at 2.8% amid job losses and global economic uncertainties, raising concerns for investor confidence.

10 juin 2026, 23:51 UTC

Brazil's Inflation Rate Expected to Rise to 4.66% YoY in May Amid Global Price Pressures and Geopolitical Tensions

10 juin 2026, 23:51 UTC

Brazil's Business Confidence Index set for June 12 release shows cautious market sentiment amid ongoing economic uncertainties.

10 juin 2026, 23:51 UTC

Check Point Software Technologies is lower in after-market hours amid broader market weakness and declines in the Systems Software sector. No specific company news was identified.

10 juin 2026, 23:51 UTC

News

ETF Constituents

The Vanguard Growth ETF is lower in after-market hours, impacted by declines in major holdings like Amazon and AMD amid broader geopolitical tensions.

10 juin 2026, 23:51 UTC

abrdn Physical Palladium Shares ETF is lower in after-market trading amid declining global equity markets due to rising tensions between the U.S. and Iran.

10 juin 2026, 23:51 UTC

Intuitive Surgical Inc shares are lower in after-market trading amid broader market declines and no specific company news identified. Concerns over geopolitical issues persist.

10 juin 2026, 23:51 UTC

American Airlines Group Inc shares are lower in after-market hours, reflecting broader market weakness amid rising bond yields and recent economic data.

10 juin 2026, 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and notable drops in major technology stocks amid geopolitical concerns.

10 juin 2026, 23:51 UTC

Correlated Moves

Alphabet Inc. shares are lower in after-market trading, reflecting broader market weakness amid geopolitical concerns and profit-taking in major tech stocks.

10 juin 2026, 23:46 UTC

Take-Two Interactive Software Inc shares are lower in after-market hours, continuing a trend of declining performance without any specific news to explain the movement.

10 juin 2026, 23:46 UTC

Workday Inc. shares are lower in after-market trading, continuing a trend of five consecutive sessions of declines amid no specific news to explain the movement.

10 juin 2026, 23:46 UTC

News

Starbucks Corp reported strong Q2 results and positive FY26 guidance. Shares are modestly higher in after-market trading, recovering from an earlier dip.

Comparaison

Variation de prix

Corvus Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

183.15% hausse

Prévisions sur 12 Mois

Moyen 31.6 USD 183.15%

Haut 40 USD

Bas 27 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.